TY - JOUR
T1 - Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability
AU - Perales-Clemente, Ester
AU - Cook, Alexandra N.
AU - Evans, Jared M.
AU - Roellinger, Samantha
AU - Secreto, Frank
AU - Emmanuele, Valentina
AU - Oglesbee, Devin
AU - Mootha, Vamsi K.
AU - Hirano, Michio
AU - Schon, Eric A.
AU - Terzic, Andre
AU - Nelson, Timothy J.
N1 - Funding Information:
We thank Israel Perez Medina for his technical assistance. This work was supported by the Marriott Mitochondrial Disorders Clinical Research Network (E.P.C., V.E., D.O., V.K.M., M.H., E.A.S., and T.J.N.), NIH P01HD080642 (E.A.S.), US Department of Defense grant W911F-15-1-0169 (E.A.S.), the Muscular Dystrophy Association (E.A.S.), the Leducq Foundation (E.P.C., T.J.N., and A.T.), the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, and NIH New Innovator Award OD007015-01 (E.P.C., A.N.C., F.S., A.T., and T.J.N.).
Publisher Copyright:
© 2016 The Authors
PY - 2016/9/15
Y1 - 2016/9/15
N2 - Functional variability among human clones of induced pluripotent stem cells (hiPSCs) remains a limitation in assembling high-quality biorepositories. Beyond inter-person variability, the root cause of intra-person variability remains unknown. Mitochondria guide the required transition from oxidative to glycolytic metabolism in nuclear reprogramming. Moreover, mitochondria have their own genome (mitochondrial DNA [mtDNA]). Herein, we performed mtDNA next-generation sequencing (NGS) on 84 hiPSC clones derived from a cohort of 19 individuals, including mitochondrial and non-mitochondrial patients. The analysis of mtDNA variants showed that low levels of potentially pathogenic mutations in the original fibroblasts are revealed through nuclear reprogramming, generating mutant hiPSCs with a detrimental effect in their differentiated progeny. Specifically, hiPSC-derived cardiomyocytes with expanded mtDNA mutations non-related with any described human disease, showed impaired mitochondrial respiration, being a potential cause of intra-person hiPSC variability. We propose mtDNA NGS as a new selection criterion to ensure hiPSC quality for drug discovery and regenerative medicine.
AB - Functional variability among human clones of induced pluripotent stem cells (hiPSCs) remains a limitation in assembling high-quality biorepositories. Beyond inter-person variability, the root cause of intra-person variability remains unknown. Mitochondria guide the required transition from oxidative to glycolytic metabolism in nuclear reprogramming. Moreover, mitochondria have their own genome (mitochondrial DNA [mtDNA]). Herein, we performed mtDNA next-generation sequencing (NGS) on 84 hiPSC clones derived from a cohort of 19 individuals, including mitochondrial and non-mitochondrial patients. The analysis of mtDNA variants showed that low levels of potentially pathogenic mutations in the original fibroblasts are revealed through nuclear reprogramming, generating mutant hiPSCs with a detrimental effect in their differentiated progeny. Specifically, hiPSC-derived cardiomyocytes with expanded mtDNA mutations non-related with any described human disease, showed impaired mitochondrial respiration, being a potential cause of intra-person hiPSC variability. We propose mtDNA NGS as a new selection criterion to ensure hiPSC quality for drug discovery and regenerative medicine.
KW - global private mutation
KW - human iPSC
KW - intra-person variability
KW - mitochondrial DNA
KW - quality control
KW - universal heteroplasmy
UR - http://www.scopus.com/inward/record.url?scp=84978646252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978646252&partnerID=8YFLogxK
U2 - 10.15252/embj.201694892
DO - 10.15252/embj.201694892
M3 - Article
C2 - 27436875
AN - SCOPUS:84978646252
SN - 0261-4189
VL - 35
SP - 1979
EP - 1990
JO - EMBO Journal
JF - EMBO Journal
IS - 18
ER -